Active Ingredient(s): Thalidomide
FDA Approved: * July 16, 1998
Pharm Company: * CELGENE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Thalomid Overview

Thalidomide, sold under the brand name Thalomid and Inmunoprin, among others, is an immunomodulatory drug and the prototype of the thalidomide class of drugs. Today, thalidomide is used mainly as a treatment of certain cancers (multiple myeloma) and of a complication of leprosy. Thalidomide was first marketed in 1957 in West Germany under the trade name Contergan. The German drug company Chemie Grünenthal developed and sold the drug. Primarily prescribed as a sedative or hypnotic, thalid...

Read more Thalomid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Thalomid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 100mg, 150mg, 200mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Thalomid: (4 results)

Sorted by National Drug Code
  • 59572-205 Thalomid 50 mg Oral Capsule by Celgene Corporation
  • 59572-210 Thalomid 100 mg Oral Capsule by Celgene Corporation
  • 59572-215 Thalomid 150 mg Oral Capsule by Celgene Corporation
  • 59572-220 Thalomid 200 mg Oral Capsule by Celgene Corporation

Other drugs which contain Thalidomide or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA